Related Experiment Video

Updated: Sep 28, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and

Ma'anit Shapira1, Mikhal Gafni, Yosef Sarne

  • 1Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.

Brain Research
|December 31, 2002
PubMed

Insights

This study reveals that prolonged exposure to opioid and cannabinoid drugs causes receptor downregulation, reducing cell responsiveness. This effect, crucial for understanding drug interactions, was observed in both homologous and heterologous desensitization.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Cell Biology

Background:

  • Opioid and cannabinoid receptors (delta-opioid (DOR) and CB1-cannabinoid) are key targets for pain management and other therapeutic interventions.
  • Understanding the long-term interactions and signaling pathways of these receptors is crucial for predicting drug efficacy and side effects.

Purpose of the Study:

  • To investigate the long-term interactions between opioid and cannabinoid drugs at the cellular signal transduction level.
  • To examine the effects of prolonged agonist exposure on receptor density, G-protein activation, and cAMP inhibition.

Main Methods:

  • Co-transfection of HEK-293 and COS-7 cells with DOR and CB1 receptors.
  • Prolonged exposure to opioid (etorphine) and cannabinoid (DALN) agonists.
  • Measurement of receptor density, G-protein activation ([35S]GTPgammaS binding), and cAMP production.

Main Results:

  • Etorphine induced homologous and heterologous desensitization in HEK-293 cells, while DALN induced only homologous desensitization.
  • Asymmetric cross-downregulation was observed: etorphine downregulated cannabinoid receptor binding, but DALN did not downregulate opioid receptor binding in HEK-293 cells.
  • COS-7 cells showed two-way cross-desensitization and DALN downregulated opioid receptor binding, indicating cell-type-specific interactions.

Conclusions:

  • A strong correlation exists between receptor downregulation and reduced cell responsiveness (desensitization).
  • Inhibition of opioid receptor downregulation using specific solutions or inhibitors also suppressed desensitization, supporting downregulation as the primary mechanism.
  • Cellular responsiveness to opioid and cannabinoid drugs is significantly influenced by receptor downregulation, with variations observed between different cell types.

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.